Baker S - Search Results

1

Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference.

Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pope J. Mancini GB, et al. Among authors: baker s. Can J Cardiol. 2011 Sep-Oct;27(5):635-62. doi: 10.1016/j.cjca.2011.05.007. Can J Cardiol. 2011. PMID: 21963058 Review.

2

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

Mancini GB, Tashakkor AY, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng DS, Pearson GJ, Pope J. Mancini GB, et al. Among authors: baker s. Can J Cardiol. 2013 Dec;29(12):1553-68. doi: 10.1016/j.cjca.2013.09.023. Epub 2013 Sep 29. Can J Cardiol. 2013. PMID: 24267801

3

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pearson GJ, Pope J, Tashakkor AY. Mancini GB, et al. Among authors: baker s. Can J Cardiol. 2016 Jul;32(7 Suppl):S35-65. doi: 10.1016/j.cjca.2016.01.003. Epub 2016 Jan 14. Can J Cardiol. 2016. PMID: 27342697 Review.

4

Optimizing Cholesterol Treatment in Patients With Muscle Complaints.

Rosenson RS, Baker S, Banach M, Borow KM, Braun LT, Bruckert E, Brunham LR, Catapano AL, Elam MB, Mancini GBJ, Moriarty PM, Morris PB, Muntner P, Ray KK, Stroes ES, Taylor BA, Taylor VH, Watts GF, Thompson PD. Rosenson RS, et al. Among authors: baker s. J Am Coll Cardiol. 2017 Sep 5;70(10):1290-1301. doi: 10.1016/j.jacc.2017.07.752. J Am Coll Cardiol. 2017. PMID: 28859793 Free article. Review.

5

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Brunham LR, Baker S, Mammen A, Mancini GBJ, Rosenson RS. Brunham LR, et al. Among authors: baker s. Cardiovasc Res. 2018 Jul 1;114(8):1073-1081. doi: 10.1093/cvr/cvy119. Cardiovasc Res. 2018. PMID: 29878063 Free PMC article.

6

Statin-associated rhabdomyolysis: is there a dose-response relationship?

Holbrook A, Wright M, Sung M, Ribic C, Baker S. Holbrook A, et al. Among authors: baker s. Can J Cardiol. 2011 Mar-Apr;27(2):146-51. doi: 10.1016/j.cjca.2010.12.024. Can J Cardiol. 2011. PMID: 21459261

7

A neuromuscular approach to statin-related myotoxicity.

Baker SK, Samjoo IA. Baker SK, et al. Can J Neurol Sci. 2008 Mar;35(1):8-21. doi: 10.1017/s0317167100007514. Can J Neurol Sci. 2008. PMID: 18380273 Review.

8

Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum.

Wu Y, Lach B, Provias JP, Tarnopolsky MA, Baker SK. Wu Y, et al. Can J Neurol Sci. 2014 Sep;41(5):638-47. doi: 10.1017/cjn.2014.22. Can J Neurol Sci. 2014. PMID: 25373816

9

Statin-associated neuromyotoxicity.

Baker SK, Tarnopolsky MA. Baker SK, et al. Timely Top Med Cardiovasc Dis. 2005 Sep 1;9:E26. Timely Top Med Cardiovasc Dis. 2005. PMID: 16215630

10

Statin-associated neuromyotoxicity.

Baker SK, Tarnopolsky MA. Baker SK, et al. Drugs Today (Barc). 2005 Apr;41(4):267-93. doi: 10.1358/dot.2005.41.4.908565. Drugs Today (Barc). 2005. PMID: 16034491 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,779 results

Search Page

Filters